Inozyme Pharma, Inc. (INZY) has 9 identified peers for comparison in the Healthcare sector. Peers include ABOS, AMLX, DAWN, ELDN, HOOK, MREO and others.
INZY has a market capitalization of $258.25M, compared to an average peer market cap of $988.48M. INZY is notably smaller than its average peer.
